The prognostic impact of downgrading and upgrading from biopsy to radical prostatectomy among men with Gleason score 7 prostate cancer
The Prostate Sep 12, 2019
Jang WS, Koh DH, Kim J, et al. - Researchers examined how downgrading and upgrading from needle biopsy (NB) to radical prostatectomy (RP) influence the prognosis of men with Gleason score (GS) 7 prostate cancer (PC). Reviewing the medical records of 3,003 patients with localized PC who underwent RP, they included 692 patients in this study; among these, 389 (56.2%) and 303 (43.8%) patients had RP GS 3 + 4 = 7 and RP GS 4 + 3 = 7 PC, respectively. On the basis of NB and RP GS, they classified 264 (38.1%), 125 (18.1%), 142 (20.5%), and 161 (23.3%) patients as 3 + 4/3 + 4, 4 + 3/3 + 4, 3 + 4/4 + 3, and 4 + 3/4 + 3, respectively. The multivariate analyses revealed a significant association of these groups with biochemical recurrence (BCR) (4 + 3/3 + 4: HR, 1.675; 3 + 4/4 + 3: HR, 1.908; and 4 + 3/4 + 3: HR, 2.699). Findings thereby suggest an independent predictive value of downgrading and upgrading from NB to RP for BCR in men with GS 7 PC, which could be due to the amount of Gleason pattern 4.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries